ArticleOrphanet journal of rare diseases2026
KLINSE: a comprehensive service model for rare disease information and care management support.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResearching rare disease (RD) knowledge is often labor-intensive and requires familiarity with a wide array of national and international databases, making it impractical in routine clinical settings and frequently insufficient. To address the gap between diagnosis and the urgent need for information on diagnosis-informed therapy and care management, the Clinical Information Center for Rare Diseases (KLINSE) was established in 2021 at the Center for Rare Diseases Tübingen. Designed as a clinician-to-clinician service, KLINSE provides up-to-date clinical knowledge and management recommendations for RDs in a timely and structured manner.
resultsBetween its start of operation in May 2021 and November 2023, KLINSE received 100 case submissions, of which 88 were accepted for processing. The majority involved ultra-rare diseases (prevalence < 1:1,000,000) and predominantly affected children and adolescents. In 58% of cases, KLINSE was contacted within one year of genetic diagnosis, while delays of up to 10 years were noted in others. KLINSE supplied information specifically requested by referring clinicians and additionally provided unsolicited yet clinically relevant insights. The most common inquiries related to treatment options, clinical trials and registries, centers of expertise, and patient organizations. Standardized feedback highlighted KLINSE’s high utility and value to clinical practice.
conclusionOur findings underscore persistent deficits in accessible disease-specific information for rare conditions. The positive reception of KLINSE demonstrates the critical role of low-threshold, expert-driven services in enhancing patient care and easing the burden on clinicians managing complex RD cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.